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signaling and exacerbates tissue damage.
INTRODUCTION:
Alcoholic liver disease (ALD) is a major chronic liver disorder that can progress from mild hepatic inflammation/injury to more severe manifestations including alcoholic 
Other methods
Additional methods and statistical analyses are described in the supplementary methods. 
Results:

The levels of serum IL-33 and sST2 correlate with the extent of liver damage in mice
To investigate the involvement of IL-33 and ST2 in ALD, we initially employed two murine models: i) chronic alcohol feeding-induced mild ALD, and ii) a recently developed model of more severe ALD, in which mice were fed with alcohol plus binge twice per week for 8 weeks (22) . In agreement with the previous report (22) , the ALT level remained modestly elevated in the model of chronic alcohol plus multiple binges ( Fig. 2C ), although higher than that in the mild ALD model (Fig. 2B&C ). This suggests that dramatic cell death is absent even in the advanced ALD model with worsened steatohepatitis and fibrosis.
Consistent with the lack of marked cell death in both models, the serum levels of IL-33
(and sST2) were not significantly increased ( Fig. 2E-F) , and IL-33-deletion did not affect alcohol-induced liver injury (Fig. 2B&C) . Interestingly, the ALT levels were significantly higher in the ST2 -/-than WT mice (Fig. 2B&C) , suggesting a possible protective function of ST2 independent of IL-33.
Significant amount of cell death is a pre-requisite for IL-33 release, but it does not occur in ALD models currently available to most of the researchers in the field. As a proofof-concept approach to investigate the role of extracellular IL-33, we produced more severe cell death by administering one low dose of CCl 4 after 4 weeks of alcohol feeding.
In this case, serum ALT activities rose to more than 2000 IU/L in WT mice ( 
ST2 attenuates chronic alcohol feeding-induced liver injury and inflammation in the absence of extracellular IL-33
The clinical data showed that IL-33 was not released in patients with compensated ALD or in heavy drinkers without overt clinical manifestation (Fig. 1B) . In mice treated with chronic alcohol or chronic alcohol plus multiple binges (Fig. 2E) , the extracellular release of IL-33 was also minimal in the absence of marked cell death. As result, IL-33-deletion did not affect liver injury in these two models. In contrast, ST2-deletion (in either male or female mice) exacerbated liver injury in both models (Fig. 2B-C and supporting Fig. S1 ).
Moreover, hepatic lipid accumulation caused by chronic alcohol feeding was significantly higher in ST2 -/-than WT mice (Fig. 3A-B) . Quantification of liver triglyceride levels confirmed that alcohol-induced steatosis is more severe in ST2 -/-than WT mice (Fig. 3C) .
Together, these data suggest that in the absence of extracellular IL-33, ST2 plays a protective role and perhaps serves as a regulator mechanism in attenuating ALD and slowing down the disease progression.
The TLR-induced NF-κB activation is a major pathway contributing to ethanolinduced hepatic inflammation. ST2 has been reported to inhibit TLR-mediated NF-κB activation. (13, 19 ) Therefore, we examined the role of ST2 in regulating alcohol-induced liver inflammation by comparing the levels of pro-inflammatory cytokines in WT and ST2 -/-mice. As shown in Fig. 4A , although the serum levels of TNF-α were similar, the levels of IL-1β and IL-6 were more than 3-fold higher in ethanol-fed ST2 -/-mice (18.91 ± 3.695 pg/ml and 17.56 ± 4.149 pg/ml respectively) than in WT mice (6.077 ± 1.176 pg/ml and 5.186 ± 1.407 pg/ml). In addition, hepatic TNF-α and IL-1β protein levels were significantly higher in ST2 -/-than WT mice, whereas hepatic IL-6 protein levels were comparable between both groups (Fig. 4B) .
We further analyzed the hepatic mRNA expression levels of pro-inflammatory cytokines/chemokines, including IL-1α, IL-1β, TNF-α, MCP-1, IL-6 and IL-12p40. As shown in Fig. 4C , the levels of the majority of these pro-inflammatory mediators were dramatically increased in EtOH-fed compared with pair-fed ST2 -/-mice. However, EtOH feeding only up-regulated IL-1β and IL-6 expression in WT mice. These results suggested that ST2-deletion augmented the inflammatory responses to chronic ethanol feeding, contributing to enhanced liver injury.
LPS causes a more severe exacerbation of alcohol-induced liver injury in ST2 -/-than WT mice
Alcohol-induced hepatic translocation of bacterial products is important in triggering hepatic inflammation through TLR signaling. As a typical TLR4 agonist, LPS has been used as a model system to investigate the TLR/NF-κB pathway in ALD. (23, 24) Previous studies have shown that LPS challenge in addition to chronic alcohol feeding exacerbates the degree of liver injury. (25) Based on the data described above, we hypothesized that ST2 -/-mice might be more susceptible to liver injury and inflammation caused by chronic alcohol feeding plus LPS.
To test this hypothesis, we treated EtOH-fed and pair-fed mice with 0.5 mg/kg of LPS after 4 weeks of feeding. Consistent with the results shown in Fig. 2B , alcohol-feeding alone induced higher levels of ALT in ST2 -/-than WT mice. LPS challenge further elevated the ALT levels in both WT and ST2 -/-mice. Interestingly, the effect of LPS was more dramatic in ST2 -/-mice, as the ALT levels were almost 2-fold higher in ST2 -/-mice than WT mice (Fig. 5A ). There were no significant differences of ALT levels in pair-fed WT and ST2 -/-mice regardless of the additional LPS stimulation.
Furthermore, compared with WT mice treated with ethanol plus LPS, the ST2 -/-mice showed significantly higher serum levels of IL-1β and TNF-α (Fig. 5B) . The hepatic mRNA expression levels of TNF-α, IL-1β, and IL-6 were compared among WT and ST2
-/-mice treated with either pair-feeding plus LPS or EtOH-feeding plus LPS (Fig. 5C ). In ST2 were all increased more than 10-fold in ST2 -/-hepatic MΦs than WT MΦs (Fig. 6A) . In mice treated with ethanol plus LPS, the expression levels of TNF-α, MCP-1 and IL-6 in hepatic MΦs from ST2 -/-mice were also significantly higher than those from WT mice (Fig.6B ). These data suggest that ST2 negatively regulates inflammatory response of increased expression levels of IL-1β, TNFα, and MCP-1 (Fig. 6C) .
It has been shown that ST2 is not expressed in naïve MΦs, but can be induced by inflammatory stimulation. (13) We purified hepatic MΦs from naïve, pair-fed and ethanolfed WT mice to determine ST2 expression. Our data show that pair-feeding slightly induced ST2 expression in hepatic MΦs, but ethanol-feeding dramatically upregulated ST2 levels in these cells (Fig. 7A ). Interestingly, ethanol-feeding also induced ST2 expression in CD45-negative non-immune cells of the liver (Fig. 7A) . However, the mRNA expression levels of pro-inflammatory mediators were markedly lower in CD45-negative cells than in hepatic MΦs (data not show), suggesting that the CD45-negative cells are not major players in alcohol-induced hepatic inflammation.
NF-κB is the key transcription factor regulating the pro-inflammatory mediators that
were significantly upregulated in ST2 -/-MΦs. To determine whether ST2 attenuates the inflammatory response of hepatic MΦs through suppressing NF-κB activation, we purified hepatic MΦs from ethanol-fed WT and ST2 -/-mice. As shown in Fig. 7B , the ratio of phosphorylated p65 to total p65 was significantly higher in ST2 -/-MΦs than WT MΦs.
Moreover, compared with WT liver MΦs, those from EtOH-fed ST2 -/-mice showed dramatically higher nuclear DNA binding activity of NF-κB p65 (Fig. 7C) . To further examine whether the inhibition of ST2 promotes NF-κB-driven promoter activity, we cotransfected WT bone marrow derived MΦs with a ST2-targeting siRNA and a NF-κB-luciferase reporter plasmid. The data demonstrated that LPS-induced NF-κB promoter activity was significantly increased when ST2 was knocked down (Fig. 7D ) Together, these data suggest that ST2 is an important negative regulator of NF-κB activation, thereby limiting inflammatory responses of hepatic MΦs and attenuating ALD.
Discussion:
One of the important mechanisms of alcohol-induced liver injury is that alcohol or and/or the IL-33/sST2 ratio correlate with the severity of ALD.
In summary, this is the first study to elucidate the role of ST2 in the pathogenesis of ALD and provide insights into the differential effects of ST2 signaling in mild versus severe ALD (Fig. 8) . Our data suggest that, during mild ALD, ST2 negatively regulates the inflammatory activation of hepatic macrophages, thereby protecting against alcoholinduced liver damage. In cases of severe liver injury, the release of extracellular IL-33 may exacerbate tissue inflammation by triggering the canonical IL-33/ST2L signaling in hepatic
MΦs. Although in our study, the IL-33/ST2L-antagonizing effect of sST2 appeared to be overridden, varying levels of sST2 in patients may be associated with disease severity.
Thus, the ratio of IL-33/sST2 could be used a biomarker to stratify disease severity and predict survival outcomes in patients with ALD. All data shown represent mean ± SEM. 
